IL17A and psoriasis: Therefore, our results suggested that L-THE downregulates the production of IL-23 and chemokines, and attenuates the IMQ-induced psoriasis like skin inflammation by inhibiting the activation of NF‐κB and IL-17A signaling pathway, and promotes the propanoate metabolism.